SRx Health Solutions, Inc. (SRXH): debt financing — SRx Health raises $15.23M in first closing of Series A preferred offering; secures up to $1B equity commitment

SRx Health Solutions, Inc.

First closing of private placement: 19,035 Series A Preferred shares and 54.5M warrants for $15.23M; additional closings at investor option up to $30.46M total.
Amendment to July 2025 Purchase Agreement increased total commitment from $50M to $1B; issued $20M convertible promissory note in connection.
Series A Preferred conversion price fixed at $0.6109; warrants exercisable at $0.6109; company seeks stockholder approval to raise authorized common from 200M to 5B shares.
Directors Lionel F. Conacher and David Allen White resigned Oct 31, 2025; committees reconstituted with Michael Young, Simon Conway and Joshua A. Epstein.

item 1.01 item 2.03 item 3.02 item 5.02 item 5.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.7

SRx Health Solutions, Inc. amended credit facility of from $50 million to $1 billion with Investor.

Instrument: credit facility
Principal: from $50 million to $1 billion
Counterparty: Investor
Event: amendment

Exact text from the filing

greement (the “Securities Purchase Agreement”) with certain accredited investors named therein. Pursuant to the Securities Purchase Agreement, up to 38,070 shares of the Company’s Series A convertible preferred stock, par value

View on SEC.gov

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

SRx Health Solutions, Inc. incurred convertible notes of $20 million with Investor.

Instrument: convertible notes
Principal: $20 million
Counterparty: Investor
Event: incurrence

Exact text from the filing

the Company issued to Investor a convertible promissory note in the aggregate principal amount of $20 million.

View on SEC.gov

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

SRx Health Solutions, Inc. issued 19,035 shares of the Series A Preferred Stock of preferred stock to certain accredited investors for aggregate proceeds of approximately $15.23 million.

Security: preferred stock
Shares: 19,035 shares of the Series A Preferred Stock
Purchaser: certain accredited investors
Consideration: aggregate proceeds of approximately $15.23 million

Exact text from the filing

On October 31, 2025, pursuant to the Securities Purchase Agreement, the Company issued and sold, and certain investors purchased, in a private placement (the “Private Placement”): 19,035 shares of the Series A Preferred Stock and 54,527,811 Warrants to purchase shares of Common Stock for aggregate proceeds of approximately $15.23 million

View on SEC.gov

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

SRx Health Solutions, Inc. issued 54,527,811 Warrants to purchase shares of Common Stock of warrant to certain accredited investors for aggregate proceeds of approximately $15.23 million.

Security: warrant
Shares: 54,527,811 Warrants to purchase shares of Common Stock
Purchaser: certain accredited investors
Consideration: aggregate proceeds of approximately $15.23 million

Exact text from the filing

On October 31, 2025, pursuant to the Securities Purchase Agreement, the Company issued and sold, and certain investors purchased, in a private placement (the “Private Placement”): 19,035 shares of the Series A Preferred Stock and 54,527,811 Warrants to purchase shares of Common Stock for aggregate proceeds of approximately $15.23 million

View on SEC.gov

102 debt financings filed in the last 30 days. Browse all debt financings →

SRx Health Solutions, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-020457

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.